NCT03808506 Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis Status WITHDRAWN Phase N/A
NCT03804931 Fecal Microbiota Transplantation for Ulcerative Colitis Status RECRUITING Phase PHASE2/PHASE3
NCT03802214 Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy Status TERMINATED Phase N/A
NCT03798691 Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab Status COMPLETED Phase PHASE4
NCT03794765 Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03781284 PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative Colitis Status COMPLETED Phase NA
NCT03774329 Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT03773952 Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients Status COMPLETED Phase PHASE2
NCT03772145 Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study Status TERMINATED Phase N/A
NCT03768219 Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis Status TERMINATED Phase PHASE1
NCT03765450 Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03760003 Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03759041 A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT03747068 The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. Status COMPLETED Phase N/A
NCT03729674 Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs Status UNKNOWN Phase N/A
NCT03724929 Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis Status TERMINATED Phase NA